Scorecard › AAPL
AAPL analyst scorecard · Apple Inc.
111 rating actions on AAPL in the last 12 months. Of 191 price targets that resolved, 46 were reached while they stood, 142 were replaced by the same firm first, and 3 fell short at their deadline. Ratings: 66% Buy-type, 28% Hold-type, 6% Sell-type. Consensus target $332, 5% below the last close.
Checked through 2026-10-29 · last close $350.22 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
24.1% 46 of 191
Replaced before the deadline
74.3%
Short at the deadline
1.6%
Ratings vs XLK
2 of 20
Buy / Hold / Sell, 12 mo
66 / 28 / 6%
Consensus target
$332 -5.1%
What the Holds say: 25 Hold-type ratings on AAPL in the last 12 months carried a median target -3% from the price on the day; 60% sat below it.
The 5 upgrades on AAPL came after an average +2.0% move in the 30 days before them.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| TD Cowen | Buy | 2026-09-10 | $400 | 0 | 5 | 5 | 0 of 1 |
| JPMorgan | Overweight | 2026-10-12 | $360 | 3 | 9 | 12 | 0 of 1 |
| Bank of America | Buy | 2026-09-23 | $370 | 0 | 19 | 19 | 0 of 1 |
| Morgan Stanley | Overweight | 2026-10-01 | $355 | 1 | 18 | 19 | 0 of 1 |
| Wedbush | Outperform | 2026-06-25 | $400 | 0 | 26 | 26 | 0 of 1 |
| Evercore ISI Group | Outperform | 2026-09-18 | $380 | 0 | 11 | 11 | 0 of 1 |
| Citigroup | Buy | 2026-07-13 | $365 | 3 | 3 | 6 | 0 of 1 |
| Barclays | Underweight | 2026-07-31 | $245 | 2 | 7 | 9 | 1 of 1 |
| Wells Fargo | Overweight | 2026-07-31 | $350 | 3 | 2 | 5 | 0 of 1 |
| Maxim Group | Buy | 2026-06-09 | $350 | 2 | 1 | 3 | — |
| Goldman Sachs | Buy | 2026-07-31 | $360 | 1 | 9 | 10 | 0 of 1 |
| Rothschild & Co | Buy | 2026-08-17 | $400 | — | — | 0 | — |
| KeyBanc | Underweight | 2026-07-14 | $250 | — | — | 0 | — |
| BNP Paribas | Outperform | 2026-04-17 | $300 | 1 | 0 | 1 | — |
| Jefferies | Underperform | 2026-08-10 | $264 | 3 | 9 | 12 | — |
| HSBC | Buy | 2026-09-08 | $366 | 0 | 1 | 2 | — |
| Argus Research | Buy | 2026-07-30 | $375 | 1 | 0 | 1 | — |
| Rosenblatt | Neutral | 2026-09-10 | $303 | 5 | 5 | 10 | — |
| Needham | Hold | 2026-10-01 | — | 3 | 4 | 7 | — |
| DA Davidson | Neutral | 2026-09-02 | $270 | 3 | 3 | 6 | — |
| UBS | Neutral | 2026-05-01 | $296 | 2 | 1 | 3 | — |
| Loop Capital | Hold | 2026-10-20 | $330 | 1 | 2 | 3 | 1 of 1 |
| MoffettNathanson | Neutral | 2026-10-20 | $283 | 1 | 0 | 2 | — |
| China Renaissance | Hold | 2026-08-04 | $280 | — | — | 0 | — |
| Baird | Outperform | 2026-07-30 | $330 | 1 | 0 | 1 | 0 of 1 |
| Bernstein | Buy | 2026-07-15 | $350 | 2 | 1 | 3 | 0 of 1 |
| KGI Securities | Hold | 2026-06-22 | $315 | 1 | 0 | 1 | — |
| Tigress Financial | Strong Buy | 2026-05-14 | $375 | 0 | 2 | 2 | 0 of 1 |
| CLSA | Outperform | 2025-12-05 | $330 | 1 | 0 | 1 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor AAPL carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-20 | MoffettNathanson | Neutral | maintained | $339.50 | $283 | running to 2027-10-20 | +1.0% |
| 2026-10-20 | Loop Capital | Buy → Hold | downgrade | $339.50 | $330 | within 5% of price when set | +1.0% |
| 2026-10-12 | JPMorgan | Overweight | maintained | $340.97 | $360 | running to 2027-10-12 | +2.6% |
| 2026-10-01 | Morgan Stanley | Overweight | maintained | $330.32 | $355 | running to 2028-04-01 | +1.6% |
| 2026-10-01 | Needham | Hold | reiterated | $330.32 | — | no target | +1.6% |
| 2026-09-29 | Morgan Stanley | Overweight | reiterated | $329.40 | $360 | replaced 2026-10-01, new $355 | +3.0% |
| 2026-09-23 | Bank of America | Buy | reiterated | $337.02 | $370 | running to 2027-09-23 | +8.6% |
| 2026-09-18 | Evercore ISI Group | Outperform | maintained | $336.13 | $380 | running to 2027-09-18 | +6.1% |
| 2026-09-17 | Bank of America | Buy | reiterated | $337.00 | $370 | running to 2027-09-17 | +8.7% |
| 2026-09-10 | TD Cowen | Buy | reiterated | $326.57 | $400 | running to 2027-09-10 | +7.1% |
| 2026-09-10 | Rosenblatt | Neutral | maintained | $326.57 | $303 | running to 2027-09-10 | +7.1% |
| 2026-09-10 | Bank of America | Buy | maintained | $326.57 | $370 | running to 2027-09-10 | +7.1% |
| 2026-09-08 | HSBC | Buy | reiterated | $316.22 | $366 | running to 2027-09-08 | +0.9% |
| 2026-09-08 | Needham | Hold | reiterated | $316.22 | — | no target | +0.9% |
| 2026-09-02 | Morgan Stanley | Overweight | reiterated | $324.96 | $360 | replaced 2026-10-01, new $355 | +7.1% |
| 2026-09-02 | DA Davidson | Neutral | maintained | $324.96 | $270 | running to 2027-09-02 | +7.1% |
| 2026-09-01 | Rosenblatt | Neutral | maintained | $325.13 | $303 | running to 2027-09-01 | +5.2% |
| 2026-08-17 | Rothschild & Co | Neutral → Buy | upgrade | $305.59 | $400 | running to 2027-08-17 | -8.4% |
| 2026-08-10 | Jefferies | Hold → Underperform | downgrade | $308.26 | $264 | running to 2027-08-10 | -2.2% |
| 2026-08-04 | China Renaissance | Buy → Hold | downgrade | $309.38 | $280 | running to 2027-08-04 | +0.2% |
| 2026-07-31 | JPMorgan | Overweight | maintained | $308.91 | $340 | reached 2026-09-25 | +4.9% |
| 2026-07-31 | TD Cowen | Buy | maintained | $308.91 | $400 | running to 2027-07-31 | +4.9% |
| 2026-07-31 | DA Davidson | Neutral | maintained | $308.91 | $270 | running to 2027-07-31 | +4.9% |
| 2026-07-31 | Wells Fargo | Overweight | maintained | $308.91 | $350 | reached 2026-10-29 | +4.9% |
| 2026-07-31 | Needham | Hold | reiterated | $308.91 | — | no target | +4.9% |
| 2026-07-31 | Rosenblatt | Neutral | maintained | $308.91 | $300 | within 5% of price when set | +4.9% |
| 2026-07-31 | Barclays | Underweight | maintained | $308.91 | $245 | running to 2027-07-31 | +4.9% |
| 2026-07-31 | Goldman Sachs | Buy | maintained | $308.91 | $360 | running to 2027-07-31 | +4.9% |
| 2026-07-31 | Morgan Stanley | Overweight | maintained | $308.91 | $360 | replaced 2026-10-01, new $355 | +4.9% |
| 2026-07-30 | Baird | Outperform | maintained | $333.43 | $330 | within 5% of price when set | +15.2% |
| 2026-07-30 | Argus Research | Buy | maintained | $333.43 | $375 | running to 2027-07-30 | +15.2% |
| 2026-07-23 | Morgan Stanley | Overweight | maintained | $321.66 | $364 | replaced 2026-07-31, new $360 | +9.3% |
| 2026-07-17 | HSBC | Hold → Buy | upgrade | $333.74 | $366 | running to 2027-07-17 | +12.8% |
| 2026-07-15 | Bernstein | Buy | maintained | $327.50 | $350 | reached 2026-10-29 | +10.5% |
| 2026-07-14 | KeyBanc | Sector Weight → Underweight | downgrade | $314.86 | $250 | running to 2027-07-14 | +8.2% |
| 2026-07-13 | Citigroup | Buy | maintained | $317.31 | $365 | running to 2027-07-13 | +9.0% |
| 2026-06-25 | Wedbush | Outperform | maintained | $275.15 | $400 | running to 2027-06-25 | -10.8% |
| 2026-06-25 | Evercore ISI Group | Outperform | reiterated | $275.15 | $365 | replaced 2026-09-18, new $380 | -10.8% |
| 2026-06-22 | KGI Securities | Outperform → Hold | downgrade | $297.01 | $315 | reached 2026-07-09 | -3.8% |
| 2026-06-18 | Bank of America | Buy | reiterated | $298.01 | $380 | replaced 2026-09-10, new $370 | -0.3% |
| 2026-06-09 | TD Cowen | Buy | maintained | $290.55 | $350 | replaced 2026-07-31, new $400 | -0.9% |
| 2026-06-09 | Maxim Group | Buy | maintained | $290.55 | $350 | reached 2026-10-29 | -0.9% |
| 2026-06-09 | Rosenblatt | Neutral | maintained | $290.55 | $276 | reached 2026-06-25 | -0.9% |
| 2026-06-09 | Morgan Stanley | Overweight | maintained | $290.55 | $360 | replaced 2026-07-23, new $364 | -0.9% |
| 2026-06-09 | Needham | Hold | reiterated | $290.55 | — | no target | -0.9% |
| 2026-06-05 | Wedbush | Outperform | reiterated | $307.34 | $400 | running to 2027-06-05 | +6.9% |
| 2026-05-26 | Bank of America | Buy | maintained | $308.33 | $380 | replaced 2026-09-10, new $370 | +13.8% |
| 2026-05-14 | Tigress Financial | Strong Buy | maintained | $298.21 | $375 | running to 2027-05-14 | +15.2% |
| 2026-05-14 | Evercore ISI Group | Outperform | maintained | $298.21 | $365 | replaced 2026-09-18, new $380 | +15.2% |
| 2026-05-08 | Wedbush | Outperform | maintained | $293.32 | $400 | running to 2027-05-08 | +13.3% |
| 2026-05-01 | UBS | Neutral | maintained | $280.14 | $296 | reached 2026-05-13 | +9.6% |
| 2026-05-01 | Maxim Group | Buy | maintained | $280.14 | $310 | reached 2026-05-27 | +9.6% |
| 2026-05-01 | TD Cowen | Buy | maintained | $280.14 | $335 | replaced 2026-06-09, new $350 | +9.6% |
| 2026-05-01 | Wedbush | Outperform | reiterated | $280.14 | $350 | replaced 2026-05-08, new $400 | +9.6% |
| 2026-05-01 | Barclays | Underweight | maintained | $280.14 | $253 | replaced 2026-07-31, new $245 | +9.6% |
| 2026-05-01 | Wells Fargo | Overweight | maintained | $280.14 | $310 | reached 2026-05-27 | +9.6% |
| 2026-05-01 | DA Davidson | Neutral | maintained | $280.14 | $270 | within 5% of price when set | +9.6% |
| 2026-05-01 | Rosenblatt | Neutral | maintained | $280.14 | $276 | within 5% of price when set | +9.6% |
| 2026-05-01 | Morgan Stanley | Overweight | maintained | $280.14 | $330 | replaced 2026-06-09, new $360 | +9.6% |
| 2026-05-01 | Needham | Hold | reiterated | $280.14 | — | no target | +9.6% |
| 2026-04-28 | UBS | Neutral | maintained | $270.71 | $287 | replaced 2026-05-01, new $296 | +8.8% |
| 2026-04-21 | Wedbush | Outperform | reiterated | $266.17 | $350 | replaced 2026-05-08, new $400 | +7.3% |
| 2026-04-21 | Rosenblatt | Neutral | maintained | $266.17 | $268 | within 5% of price when set | +7.3% |
| 2026-04-17 | BNP Paribas | Neutral → Outperform | upgrade | $270.23 | $300 | reached 2026-05-15 | +8.1% |
| 2026-04-14 | Bank of America | Buy | maintained | $258.83 | $325 | replaced 2026-05-26, new $380 | +3.5% |
| 2026-03-31 | Wedbush | Outperform | reiterated | $253.79 | $350 | replaced 2026-05-08, new $400 | -3.9% |
| 2026-03-27 | Wedbush | Outperform | reiterated | $248.80 | $350 | replaced 2026-05-08, new $400 | -9.3% |
| 2026-03-23 | Morgan Stanley | Overweight | reiterated | $251.49 | $315 | replaced 2026-05-01, new $330 | -5.0% |
| 2026-03-23 | Bank of America | Buy | maintained | $251.49 | $320 | replaced 2026-04-14, new $325 | -5.0% |
| 2026-03-05 | Wedbush | Outperform | reiterated | $260.29 | $350 | replaced 2026-05-08, new $400 | -3.4% |
| 2026-03-05 | Rosenblatt | Neutral | maintained | $260.29 | $268 | within 5% of price when set | -3.4% |
| 2026-03-03 | Barclays | Underweight | maintained | $263.75 | $248 | reached 2026-03-20 | +1.6% |
| 2026-02-17 | Wedbush | Outperform | reiterated | $263.88 | $350 | replaced 2026-05-08, new $400 | +3.3% |
| 2026-01-30 | Jefferies | Hold | maintained | $259.48 | $287 | reached 2026-05-06 | -4.5% |
| 2026-01-30 | Maxim Group | Hold → Buy | upgrade | $259.48 | $300 | replaced 2026-05-01, new $310 | -4.5% |
| 2026-01-30 | JPMorgan | Overweight | maintained | $259.48 | $325 | reached 2026-07-15 | -4.5% |
| 2026-01-30 | TD Cowen | Buy | reiterated | $259.48 | $325 | replaced 2026-05-01, new $335 | -4.5% |
| 2026-01-30 | Barclays | Underweight | maintained | $259.48 | $239 | replaced 2026-03-03, new $248 | -4.5% |
| 2026-01-30 | DA Davidson | Neutral | maintained | $259.48 | $270 | within 5% of price when set | -4.5% |
| 2026-01-30 | Wedbush | Outperform | reiterated | $259.48 | $350 | replaced 2026-05-08, new $400 | -4.5% |
| 2026-01-30 | Needham | Hold | reiterated | $259.48 | — | no target | -4.5% |
| 2026-01-30 | Rosenblatt | Neutral | maintained | $259.48 | $267 | within 5% of price when set | -4.5% |
| 2026-01-26 | JPMorgan | Overweight | maintained | $255.41 | $315 | replaced 2026-01-30, new $325 | -6.6% |
| 2026-01-26 | Jefferies | Hold | maintained | $255.41 | $276 | replaced 2026-01-30, new $287 | -6.6% |
| 2026-01-20 | Citigroup | Buy | maintained | $246.70 | $315 | reached 2026-06-02 | -9.8% |
| 2026-01-20 | Evercore ISI Group | Outperform | reiterated | $246.70 | $330 | replaced 2026-05-14, new $365 | -9.8% |
| 2026-01-13 | Wedbush | Outperform | reiterated | $261.05 | $350 | replaced 2026-05-08, new $400 | -6.2% |
| 2026-01-12 | Wedbush | Outperform | reiterated | $260.25 | $350 | replaced 2026-05-08, new $400 | -6.5% |
| 2026-01-09 | Evercore ISI Group | Outperform | maintained | $259.37 | $330 | replaced 2026-05-14, new $365 | -7.0% |
| 2025-12-17 | Morgan Stanley | Overweight | maintained | $271.84 | $315 | replaced 2026-05-01, new $330 | +1.6% |
| 2025-12-09 | Citigroup | Buy | maintained | $277.18 | $330 | replaced 2026-01-20, new $315 | +3.2% |
| 2025-12-08 | Evercore ISI Group | Outperform | maintained | $277.89 | $325 | replaced 2026-01-09, new $330 | +3.5% |
| 2025-12-08 | Wedbush | Outperform | maintained | $277.89 | $350 | replaced 2026-05-08, new $400 | +3.5% |
| 2025-12-05 | CLSA | Outperform | maintained | $278.78 | $330 | reached 2026-07-16 | +3.2% |
| 2025-12-02 | Loop Capital | Buy | maintained | $286.19 | $325 | reached 2026-07-15 | +5.8% |
| 2025-11-04 | Rosenblatt | Neutral | maintained | $270.04 | $250 | reached 2026-01-20 | — |
| 2025-10-31 | Wells Fargo | Overweight | maintained | $270.37 | $300 | replaced 2026-05-01, new $310 | — |
| 2025-10-31 | Barclays | Underweight | maintained | $270.37 | $230 | replaced 2026-01-30, new $239 | — |
| 2025-10-31 | Citigroup | Buy | maintained | $270.37 | $315 | replaced 2025-12-09, new $330 | — |
| 2025-10-31 | JPMorgan | Overweight | maintained | $270.37 | $305 | replaced 2026-01-26, new $315 | — |
| 2025-10-31 | Goldman Sachs | Buy | maintained | $270.37 | $320 | reached 2026-07-15 | — |
| 2025-10-31 | Jefferies | Underperform → Hold | upgrade | $270.37 | $247 | reached 2026-01-20 | — |
| 2025-10-31 | TD Cowen | Buy | maintained | $270.37 | $325 | replaced 2026-05-01, new $335 | — |
| 2025-10-31 | Argus Research | Buy | maintained | $270.37 | $325 | reached 2026-07-15 | — |
| 2025-10-31 | UBS | Neutral | maintained | $270.37 | $280 | within 5% of price when set | — |
| 2025-10-31 | DA Davidson | Neutral | maintained | $270.37 | $270 | within 5% of price when set | — |
| 2025-10-31 | Evercore ISI Group | Outperform | maintained | $270.37 | $300 | replaced 2025-12-08, new $325 | — |
| 2025-10-31 | Rosenblatt | Neutral | maintained | $270.37 | $250 | reached 2026-01-20 | — |
| 2025-10-31 | Morgan Stanley | Overweight | maintained | $270.37 | $305 | replaced 2025-12-17, new $315 | — |
| 2025-10-31 | Bank of America | Buy | maintained | $270.37 | $325 | replaced 2026-03-23, new $320 | — |
| 2025-10-29 | Bank of America | Buy | maintained | $269.70 | $320 | replaced 2025-10-31, new $325 | — |
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.